Clinical Trial Update: Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cediranib with paclitaxel and carboplatin in stage IIIB/IV non-small cell lung cancer has completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cediranib (Cediranib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-12-22